[{"@context":"http:\/\/schema.org\/","@type":"BlogPosting","@id":"https:\/\/wiki.edu.vn\/wiki22\/2021\/01\/01\/bectumomab-wikipedia\/#BlogPosting","mainEntityOfPage":"https:\/\/wiki.edu.vn\/wiki22\/2021\/01\/01\/bectumomab-wikipedia\/","headline":"Bectumomab – Wikipedia","name":"Bectumomab – Wikipedia","description":"Bectumomab (vermarktet unter dem Handelsnamen LymphoScan) ist ein monoklonaler Maus-Antik\u00f6rper, der mit dem radioaktiven Isotop Technetium-99m markiert ist. Es wird","datePublished":"2021-01-01","dateModified":"2021-01-01","author":{"@type":"Person","@id":"https:\/\/wiki.edu.vn\/wiki22\/author\/lordneo\/#Person","name":"lordneo","url":"https:\/\/wiki.edu.vn\/wiki22\/author\/lordneo\/","image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/44a4cee54c4c053e967fe3e7d054edd4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/44a4cee54c4c053e967fe3e7d054edd4?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Enzyklop\u00e4die","logo":{"@type":"ImageObject","@id":"https:\/\/wiki.edu.vn\/wiki4\/wp-content\/uploads\/2023\/08\/download.jpg","url":"https:\/\/wiki.edu.vn\/wiki4\/wp-content\/uploads\/2023\/08\/download.jpg","width":600,"height":60}},"image":{"@type":"ImageObject","@id":"https:\/\/en.wikipedia.org\/wiki\/Special:CentralAutoLogin\/start?type=1x1","url":"https:\/\/en.wikipedia.org\/wiki\/Special:CentralAutoLogin\/start?type=1x1","height":"1","width":"1"},"url":"https:\/\/wiki.edu.vn\/wiki22\/2021\/01\/01\/bectumomab-wikipedia\/","wordCount":990,"articleBody":"Bectumomab (vermarktet unter dem Handelsnamen LymphoScan) ist ein monoklonaler Maus-Antik\u00f6rper, der mit dem radioaktiven Isotop Technetium-99m markiert ist. Es wird verwendet, um Non-Hodgkin-Lymphome zu erkennen.[1][2]Verweise[edit]^ “WHO Drug Information” (PDF). Archiviert von das Original (PDF) am 04.06.2011. Abgerufen 2009-09-23.^ Lamonica D., Czuczman M., Nabi H., Klippenstein D., Grossman Z. (Dezember 2002). Radioimmunoscintigraphie (RIS) mit Bectumomab (Tc99m markiert IMMU-LL2, Lymphoscan) bei der Beurteilung des rezidivierenden Non-Hodgkin-Lymphoms (NHL). Krebs-Biotherapie & Radiopharmazeutika. 17 (6): 689\u201397. doi:10.1089 \/ 108497802320970307. PMID 12537673.Tumor "},{"@context":"http:\/\/schema.org\/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https:\/\/wiki.edu.vn\/wiki22\/#breadcrumbitem","name":"Enzyklop\u00e4die"}},{"@type":"ListItem","position":2,"item":{"@id":"https:\/\/wiki.edu.vn\/wiki22\/2021\/01\/01\/bectumomab-wikipedia\/#breadcrumbitem","name":"Bectumomab – Wikipedia"}}]}]